Popular Articles

St. Petersburg Times Examines Work Of Paul Farmer, Potential Candidate For USAID, State Department Position
The St. Petersburg Times examines the work of Paul Farmer - "the Harvard-educated doctor who, starting in Haiti, built a multinational organization on the radical idea that poor patients deserve the same care as rich ones" and is reportedly being considered for a high-level job with USAID or the State Department. The newspaper reports that though it"s "not a sure thing, even his candidacy indicates how far the international aid establishment has come around to Farmer"s way of thinking, health care experts say."
buy viagra
New Data Demonstrate Potential For Early Detection Of Alzheimer's Disease Using New Diagnostic Technology, Which Could Lead To Improved Treatment
Data published in the June issue of the Journal of Alzheimer"s Disease demonstrated that minimally-invasive biospectroscopy was able to identify changes in oxidative stress (OS) levels in blood plasma, which may prove to be a useful biomarker in the early detection of Alzheimer"s disease. There is currently no accepted laboratory test for diagnosing Alzheimer"s disease.
News of the day
Labopharm Receives Complete Response Letter From The U.S. FDA For Novel Antidepressant
Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for the new drug application (NDA) submission of its novel formulation of the antidepressant trazodone.
Public Health

WHO Closer To Declaring Swine Flu Outbreak A Pandemic

The WHO on Tuesday said it was "getting closer" to declaring the H1N1 (swine) flu outbreak to be a pandemic, as the virus continues to spread to people outside of North America, and in populations "as far apart as Britain, Spain, Japan, Chile and Australia," the AP/Washington Post reports (Jordans, AP/Washington Post, 6/2). The WHO on Wednesday confirmed that 66 countries have officially reported 19,273 cases of H1N1, including 117 deaths. A full list of country cases and deaths is available here (WHO Influenza A(H1N1) - update 43, 6/3). "We still are waiting for evidence of really widespread community activity in these countries, and so it"s fair to say that they are in transition and are not quite there yet, which is why we are not in phase 6 yet," WHO"s Assistant Director General Keiji Fukuda said (AP/Washington Post, 6/2). "Phase 6 is a declaration that many member countries have long feared could mean economic disaster," CNN writes (Sloane, CNN, 6/2) because, as Bloomberg describes, it "may spur some countries to restrict travel, ban public events and adopt other measures that aren"t needed for mild flu, worsening the deepest economic slump since the Great Depression." Michael Leavitt, former HHS secretary, said, "The formalization of an influenza pandemic does have cascading consequenceṣ€¦The decision ought not to be taken lightly" (Gale, Bloomberg, 6/2). Such concerns have forced the WHO to reevaluate the pandemic alert scale - a tool that takes into consideration the geographic spread of a new virus, but not its severity (Kaiser Daily Global Health Policy Report, 5/26). s "familiar with the agency"s plans" said WHO Director-General Margaret Chan and her colleagues spent seven hours "consulting experts on how to explain that swine flu is global, but not severe. ̣€¦ [S]ometime in the next 10 days, [the WHO] will declare the first flu pandemic in 41 years, said the people, who spoke on condition of anonymity because the WHO"s deliberations are private. WHO is using the time before the announcement to help member states prepare," according to Bloomberg (Bloomberg, 6/2). If the WHO "declares [swine flu] a Level 6 pandemic, Dr. Fukuda said, it may add a caveat indicating that the virus is not very lethal," the New York Times writes. "Still, measuring severity can be tricky because the same flu virus may theoretically kill far more people in a poor country with widespread malnutrition and AIDS than it does in a wealthy, well-fed nation" (McNeil, New York Times, 6/3). World Bank Approves $500M For Low-, Middle-Income Countries To Prevent, Control Outbreaks The World Bank on Tuesday approved $500 million to "expand an existing fund to help developing countries prevent and control outbreaks of influenza, including the new H1N1 virus," Reuters reports (Wroughton, Reuters, 6/2). The money expands upon the World Bank"s preexisting $500 million credit line created in 2006 to help countries to deal with the H5N1 (bird) flu. "Low- and middle-income countries can access the financing to pay for drugs, medical equipment, hospital care, human and livestock health surveillance, and offset the economic and social costs associated with pandemic flu, the bank said in a release," according to Dow Jones Newswires/Wall Street Journal (Barkley, Dow Jones Newswires/Wall Street Journal, 6/2). "This is a particularly bad time for a pandemic to occur given that developing countries are more vulnerable now because of the compounded effects of the food, fuel and financial crises," said Jeff Gutman, the World Bank"s vice president for operations, adding, "The worst-case scenarios for pandemic flu point to a significant economic impact, with poor people in developing countries likely to be hit hardest" (Xinhua, 6/2). Obama Requests Additional $2B From Congress To Deal With H1N1 President Obama on Tuesday requested from Congress "an additional $2 billion to address the H1N1 flu strain circulating around the United States," Reuters reports. The funds would be in addition to Obama"s previous request of Congress for $1.5 billion request for the purchase of antivirals, vaccine development and other preparedness equipment. In a letter to House of Representatives Speaker Nancy Pelosi (D-Calif.), Obama described his request for additional funds as being "out of an abundance of caution," adding there "remains much uncertainty about the outbreak and its potential to return during the upcoming flu season in the United States" (Allen, Reuters, 6/2). U.S. Feds Award $90M Contract to MedImmune For H1N1 Vaccine Development U.S. health officials on Monday awarded a $90 million contract to the pharmaceutical company MedImmune - makers of seasonal FluMist vaccine - to develop a vaccine that offers protection against the H1N1 (swine flu) virus, the Washington Post reports. The article explores the differences between an H1N1 vaccine developed by MedImmune to the more traditional flu vaccines made by Novartis, Sanofi Pasteur and GlaxoSmithKline - all recently awarded H1N1 vaccine contracts, including that MedImmune"s H1N1 vaccine would be administered nasally and could produce a stronger immune response to the virus (Rosenwald, Washington Post, 6/2). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):